Vaxcyte Inc (PCVX)

Currency in USD
29.90
-0.11(-0.37%)
Closed·
After Hours
29.900.00(0.00%)
·
PCVX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PCVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.2930.27
52 wk Range
27.66121.06
Key Statistics
Prev. Close
30.01
Open
30.08
Day's Range
29.29-30.27
52 wk Range
27.66-121.06
Volume
1.96M
Average Volume (3m)
1.62M
1-Year Change
-59.4%
Book Value / Share
24.85
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PCVX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
114.88
Upside
+284.20%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Vaxcyte Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Vaxcyte Inc Company Profile

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Compare PCVX to Peers and Sector

Metrics to compare
PCVX
Peers
Sector
Relationship
P/E Ratio
−7.1x−3.5x−0.5x
PEG Ratio
−0.69−0.010.00
Price/Book
1.3x2.2x2.6x
Price / LTM Sales
-9.5x3.3x
Upside (Analyst Target)
323.0%196.4%43.5%
Fair Value Upside
Unlock6.6%6.8%Unlock

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 114.88
(+284.20% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-1.22 / -1.17
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PCVX Income Statement

People Also Watch

18.23
SRPT
+1.50%
5.29
REPL
-3.47%
31.96
SRRK
+1.78%
35.00
RVMD
+0.14%
34.11
CYTK
-3.23%

FAQ

What Stock Exchange Does Vaxcyte Trade On?

Vaxcyte is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Vaxcyte?

The stock symbol for Vaxcyte is "PCVX."

What Is the Vaxcyte Market Cap?

As of today, Vaxcyte market cap is 3.88B.

What Is Vaxcyte's Earnings Per Share (TTM)?

The Vaxcyte EPS (TTM) is -4.13.

When Is the Next Vaxcyte Earnings Date?

Vaxcyte will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is PCVX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Vaxcyte Stock Split?

Vaxcyte has split 0 times.

How Many Employees Does Vaxcyte Have?

Vaxcyte has 414 employees.

What is the current trading status of Vaxcyte (PCVX)?

As of 09 Aug 2025, Vaxcyte (PCVX) is trading at a price of 29.90, with a previous close of 30.01. The stock has fluctuated within a day range of 29.29 to 30.27, while its 52-week range spans from 27.66 to 121.06.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.